Castle Biosciences, Inc. (CSTL)

Castle Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	85.56	119.71	98.84	122.95	329.63	409.85
Short-Term Investments	201.99	173.42	144.26	135.68	-	-
Cash & Short-Term Investments	287.54	293.13	243.1	258.63	329.63	409.85
Cash Growth	2.77%	20.58%	-6.00%	-21.54%	-19.57%	314.64%
Receivables	50.68	51.22	38.3	23.48	17.28	12.76
Inventory	8.65	8.14	7.94	3.98	2.02	2.22
Prepaid Expenses	10.7	7.67	6.29	6.21	4.81	4.77
Total Current Assets	357.57	360.15	295.64	292.29	353.74	429.59
Property, Plant & Equipment	100.04	62.71	37.74	26.5	16.88	7.1
Goodwill	10.69	10.69	10.69	10.69	-	-
Other Intangible Assets	91.16	95.54	106.64	115.66	88.92	-
Other Long-Term Assets	3.33	2.15	2.63	2.2	3.02	2.63
Total Assets	562.79	531.24	453.34	447.33	462.57	439.33
Accounts Payable	12.21	6.9	10.27	4.73	2.55	2.1
Accrued Expenses	37.8	38.7	35.26	29.21	20.5	11.81
Current Portion of Long-Term Debt	-	0.28	-	-	-	-
Current Portion of Leases	1.45	1.77	1.21	1.93	1.28	-
Current Income Taxes Payable	1.25	1.08	0.4	-	-	-
Other Current Liabilities	2.6	0.67	0.54	0.27	0.56	6.97
Total Current Liabilities	55.31	49.39	47.67	36.13	24.89	20.88
Long-Term Debt	10.05	9.75	-	-	-	-
Long-Term Leases	25.64	14.66	14.2	11.62	7.02	-
Long-Term Deferred Tax Liabilities	3.24	1.61	0.21	0.43	0.64	-
Other Long-Term Liabilities	1.5	-	-	-	18.29	2.76
Total Liabilities	95.74	75.4	62.07	48.18	50.83	23.64
Common Stock	0.03	0.03	0.03	0.03	0.03	0.03
Additional Paid-In Capital	688.73	655.7	609.48	560.41	505.48	478.16
Retained Earnings	-221.95	-200.13	-218.37	-160.91	-93.77	-62.5
Comprehensive Income & Other	0.24	0.23	0.14	-0.38	-	-
Total Common Equity	467.05	455.84	391.27	399.15	411.74	415.69
Shareholders' Equity	467.05	455.84	391.27	399.15	411.74	415.69
Total Liabilities & Equity	562.79	531.24	453.34	447.33	462.57	439.33
Total Debt	37.14	26.45	15.41	13.55	8.31	-
Net Cash (Debt)	250.4	266.69	227.69	245.08	321.33	409.85
Net Cash Growth	-1.04%	17.13%	-7.09%	-23.73%	-21.60%	455.94%
Net Cash Per Share	8.73	9.12	8.50	9.41	12.78	21.65
Filing Date Shares Outstanding	29.19	28.51	27.45	26.58	25.41	24.98
Total Common Shares Outstanding	29.16	28.48	27.41	26.55	25.38	24.81
Working Capital	302.26	310.76	247.97	256.16	328.86	408.72
Book Value Per Share	16.02	16.00	14.27	15.03	16.22	16.75
Tangible Book Value	365.2	349.61	273.93	272.8	322.82	415.69
Tangible Book Value Per Share	12.52	12.27	9.99	10.27	12.72	16.75
Land	7.25	7.25	-	-	-	-
Machinery	40.86	32.48	22.92	15.35	7.47	3.78
Construction In Progress	38.81	9.61	0.64	1.28	0.03	3.59
Leasehold Improvements	14.81	14.62	9.99	5.17	5.04	1.39

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q